paraquat has been researched along with amitriptyline in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Glen, RC; Lowe, R; Mitchell, JB | 1 |
| Marinov, P; Nenov, DS; Nenov, VD; Sabeva, J | 1 |
| Chen, J; Cheng, B; Jian, X; Li, C | 1 |
1 review(s) available for paraquat and amitriptyline
| Article | Year |
|---|---|
Current applications of plasmapheresis in clinical toxicology.
Topics: Amitriptyline; Female; Humans; Male; Mushroom Poisoning; Paraquat; Plasmapheresis; Poisoning; Risk Assessment; Sensitivity and Specificity; Survival Rate; Toxicology; Treatment Outcome | 2003 |
3 other study(ies) available for paraquat and amitriptyline
| Article | Year |
|---|---|
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
Therapeutic potential of amitriptyline for paraquat-induced pulmonary fibrosis: Involvement of caveolin-1-mediated anti-epithelial-mesenchymal transition and inhibition of apoptosis.
Topics: Amitriptyline; Animals; Apoptosis; Cadherins; Caveolin 1; Interleukin-17; Lung; Mice; Mice, Inbred C57BL; Paraquat; Pulmonary Fibrosis; RNA, Small Interfering | 2023 |